Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.

• Status: Active, not recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study investigates the possibility that levetiracetam may improve the symptoms of chronic post-stroke aphasia.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kessler Foundation
• Collaborator: UCB Pharma
• Treatments: Etiracetam; Levetiracetam; Piracetam

Criteria

Inclusion Criteria:

• Stroke

• Aphasia

• Can give consent

Exclusion Criteria:

• Renal failure

• Pregnancy

• Other neurological condition